AAAAAA

   
Results: 1-13 |
Results: 13
Influence of gender and oral contraceptives on CYP2D6 and CY2ZC19 activityin healthy volunteers
Authors: Hagg, S Spigset, O Dahlqvist, R
Citation: S. Hagg et al., Influence of gender and oral contraceptives on CYP2D6 and CY2ZC19 activityin healthy volunteers, BR J CL PH, 51(2), 2001, pp. 169-173
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes
Authors: Hagg, S Spigset, O Lakso, HA Dahlqvist, R
Citation: S. Hagg et al., Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes, EUR J CL PH, 57(6-7), 2001, pp. 493-497
Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice - A cohort study
Authors: Beermann, B Melander, H Sawe, J Ulleryd, C Dahlqvist, R
Citation: B. Beermann et al., Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice - A cohort study, EUR J CL PH, 57(4), 2001, pp. 309-311
The isotopic composition of Nd in a boreal river: A reflection of selective weathering and colloidal transport
Authors: Andersson, PS Dahlqvist, R Ingri, J Gustafsson, O
Citation: Ps. Andersson et al., The isotopic composition of Nd in a boreal river: A reflection of selective weathering and colloidal transport, GEOCH COS A, 65(4), 2001, pp. 521-527
Effect of caffeine on clozapine pharmacokinetics in healthy volunteers
Authors: Hagg, S Spigset, O Mjorndal, T Dahlqvist, R
Citation: S. Hagg et al., Effect of caffeine on clozapine pharmacokinetics in healthy volunteers, BR J CL PH, 49(1), 2000, pp. 59-63
HMG-CoA reductase inhibitors and myotoxicity
Authors: Ucar, M Mjorndal, T Dahlqvist, R
Citation: M. Ucar et al., HMG-CoA reductase inhibitors and myotoxicity, DRUG SAFETY, 22(6), 2000, pp. 441-457
Citalopram pharmacokinetics in patients with chronic renal failure and theeffect of haemodialysis
Authors: Spigset, O Hagg, S Stegmayr, B Dahlqvist, R
Citation: O. Spigset et al., Citalopram pharmacokinetics in patients with chronic renal failure and theeffect of haemodialysis, EUR J CL PH, 56(9-10), 2000, pp. 699-703
Attitudes to reporting adverse drug reactions in northern Sweden
Authors: Backstrom, M Mjorndal, T Dahlqvist, R Nordkvist-Olsson, T
Citation: M. Backstrom et al., Attitudes to reporting adverse drug reactions in northern Sweden, EUR J CL PH, 56(9-10), 2000, pp. 729-732
Change in managing editor
Authors: Dahlqvist, R Mager, T
Citation: R. Dahlqvist et T. Mager, Change in managing editor, EUR J CL PH, 56(5), 2000, pp. 351-351
Co-ordinating editor's comments on the letter to the editors by A. Hemheimer
Authors: Dahlqvist, R
Citation: R. Dahlqvist, Co-ordinating editor's comments on the letter to the editors by A. Hemheimer, EUR J CL PH, 55(11-12), 2000, pp. 883-884
The paraxanthine : caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
Authors: Spigset, O Hagg, S Soderstrom, E Dahlqvist, R
Citation: O. Spigset et al., The paraxanthine : caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?, PHARMACOGEN, 9(3), 1999, pp. 409-412
Absence of interaction between erythromycin and a single dose of clozapine
Authors: Hagg, S Spigset, O Mjorndal, T Granberg, K Persbo-Lundqvist, G Dahlqvist, R
Citation: S. Hagg et al., Absence of interaction between erythromycin and a single dose of clozapine, EUR J CL PH, 55(3), 1999, pp. 221-226
Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance
Authors: Spigset, O Hagg, S Soderstrom, E Dahlqvist, R
Citation: O. Spigset et al., Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance, EUR J CL PH, 54(12), 1999, pp. 943-946
Risultati: 1-13 |